#lynchsyndrome
#CAPP3
Lynch syndrome carriers face up to 80% lifetime CRC risk! The ongoing CAPP3 trial is exploring optimal aspirin doses for Lynch Syndrome
#Onco404 #Cancer #Kanser #ClinicalTrials #LynchSyndrome #ColorectalCancer #EndometrialCancer #Aspirin #CancerPrevention #MedSky #OncSky
0
0
0
0